[HTML][HTML] Long-term outcomes of C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis in children

A Kirpalani, N Jawa, WE Smoyer, C Licht… - Kidney International …, 2020 - Elsevier
Introduction The reclassification of membranoproliferative glomerulonephritis (MPGN) into
immune-complex MPGN (IC-MPGN) and C3 glomerulopathy (C3G) has provided insights …

[HTML][HTML] Novel assays to distinguish between properdin-dependent and properdin-independent C3 nephritic factors provide insight into properdin-inhibiting therapy

MAHM Michels, NCAJ Van de Kar… - Frontiers in …, 2019 - frontiersin.org
C3 glomerulopathy (C3G) is an umbrella classification for severe renal diseases
characterized by predominant staining for complement component C3 in the glomeruli. The …

[HTML][HTML] C3-glomerulopathy autoantibodies mediate distinct effects on complement C3-and C5-convertases

F Zhao, S Afonso, S Lindner, A Hartmann… - Frontiers in …, 2019 - frontiersin.org
C3 glomerulopathy (C3G) is a severe kidney disease, which is caused by defective
regulation of the alternative complement pathway. Disease pathogenesis is heterogeneous …

Atypical hemolytic uremic syndrome and complement blockade: established and emerging uses of complement inhibition

RM Hanna, M Barsoum, A Vandross… - Current opinion in …, 2019 - journals.lww.com
Many 'hemolysis syndromes' overlap clinically with aHUS, and we review the literature on
the treatment of these conditions with complement inhibition. New reports on the treatment of …

[HTML][HTML] Overactivity of alternative pathway convertases in patients with complement-mediated renal diseases

MAHM Michels, NCAJ Van de Kar, M Okrój… - Frontiers in …, 2018 - frontiersin.org
Overactivation of the alternative pathway of the complement system is associated with the
renal diseases atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G) …

Therapeutic small interfering rna targeting complement C3 in a mouse model of C3 glomerulopathy

C Zanchi, M Locatelli, D Cerullo, V Aumiller… - The Journal of …, 2022 - journals.aai.org
Alternative pathway complement dysregulation with abnormal glomerular C3 deposits and
glomerular damage is a key mechanism of pathology in C3 glomerulopathy (C3G). No …

[HTML][HTML] Spectrum of kidney involvement in patients with myelodysplastic syndromes

N Schwotzer, F Provot, S Ville, L Daniel… - Kidney International …, 2021 - Elsevier
Introduction Myelodysplastic syndromes (MDS) are characterized by a high prevalence of
associated autoimmune manifestations. Kidney involvement has been rarely reported in …

Predictors of poor kidney outcome in children with C3 glomerulopathy

AS Pınarbaşı, I Dursun, I Gokce, E Çomak, S Saygılı… - Pediatric …, 2021 - Springer
Abstract Background C3 glomerulopathy (C3G) is characterized by heterogeneous clinical
presentation, outcome, and predominant C3 accumulation in glomeruli without significant …

Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathy

C Zanchi, M Locatelli, D Cerullo, V Aumiller… - Molecular …, 2024 - Elsevier
Complement alternative pathway (AP) dysregulation drives C3 glomerulopathy (C3G), a rare
renal disorder characterized by glomerular C3 deposition and glomerular damage, for which …

C3 glomerulopathy and atypical hemolytic uremic syndrome: an updated review of the literature on alternative complement pathway disorders

K Turkmen, I Baloglu, H Ozer - International Urology and Nephrology, 2021 - Springer
The complement system plays a significant role within the pathological process of C3
glomerulopathy (C3GP) and atypical hemolytic uremic syndrome (aHUS). In daily practice …